Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical Trial.

Autor: Ahmady, Shima, Jansen, Maud H. E., Nelemans, Patty J., Kessels, Janneke P. H. M., Arits, Aimee H. M. M., de Rooij, Michette J. M., Essers, Brigitte A. B., Quaedvlieg, Patricia J. F., Kelleners-Smeets, Nicole W. J., Mosterd, Klara

Publikováno v: JAMA Dermatology; Jun2022, Vol. 158 Issue 6, p634-640, 7p

Aesthetic evaluation after non-invasive treatment for superficial basal cell carcinoma

Autor: Mosterd, K., Arits, A. H. M. M., Nelemans, P. J., Kelleners-Smeets, N. W. J.

Publikováno v: Journal of the European Academy of Dermatology and Venereology, 27(5), 647-650. Wiley

Background Cosmetic results following non-invasive treatments are difficult to compare. Although qualified objective scar assessment scales are available, they are not used in dermatological studies. Usually a 4-point scale is used in dermatological

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::961ff1192bb9048484032f140e244b4a
https://cris.maastrichtuniversity.nl/en/publications/ad1ec765-c9eb-45cf-a2f4-325417e03a7b

Trends in the incidence of basal cell carcinoma by histopathological subtype

Autor: Arits, A. H. M. M., Schlangen, M. H. J., Nelemans, P. J., Kelleners-Smeets, N. W. J.

Publikováno v: Journal of the European Academy of Dermatology and Venereology, 25(5), 565-569. Wiley

Background As a result of the high prevalence, basal cell carcinoma (BCC) causes a significant and expensive health care problem. Objective In this study, we evaluate the proportional increase in BCC by histological subtype over the last two decades.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::2a76444e62c8ce8d6859f9d07286734c
https://cris.maastrichtuniversity.nl/en/publications/dd951898-98e3-458d-ac8b-24ed72e37faf

Basal cell carcinoma and trichoepithelioma: a possible matter of confusion.

Autor: Arits, Aimée H. M. M., Parren, Lizelotte J. M. T., van Marion, Arienne M. W., Sommer, Anja, Frank, Jorge, Kelleners-Smeets, Nicole W. J.

Publikováno v: International Journal of Dermatology; Nov2008 Supplement, Vol. 47, p13-17, 5p, 2 Color Photographs, 2 Charts

Prognostic factors for treatment failure of imiquimod treatment in basal cell carcinoma - an observational study.

Autor: Verkouteren BJA; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Oostewechel LCF; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands., Nelemans PJ; Department of Epidemiology, Maastricht University Medical Centre, Maastricht, The Netherlands., Sinx KAE; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Arits AHMM; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.; Department of Dermatology, Catherina Hospital, Eindhoven, The Netherlands., Vernemmen AIP; Department of Pathology, Maastricht University, Maastricht, The Netherlands., Winnepenninckx VJL; Department of Pathology, Maastricht University, Maastricht, The Netherlands., Kelleners-Smeets NWJ; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Mosterd K; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2022 Jun; Vol. 36 (6), pp. e475-e477. Date of Electronic Publication: 2022 Feb 08.